Vnitřní lékařství, 2005 (vol. 51), issue 12

Jmenný rejstřík. Původní práce, editorialy, přehledné referáty, doškolování, popisy případů a krátká sdělení

Vnitr Lek 2005, 51(12):1420-1430  

Věcný rejstřík

Vnitr Lek 2005, 51(12):1431-1440  

Editorial

Studie ASCOT: konec léčby hypertenze beta-blokátory? - editorial

J. Filipovský

Vnitr Lek 2005, 51(12):1338-1340  

Original articles

The relation of GERD, bronchial asthma and symptomatology from ear, nose and throught regions

Z. Matyášová, B. Novotná, M. Matulová, J. Dolina, R. Kroupa, Z. Láníková, V. Znojil, A. Hep, P. Dítě

Vnitr Lek 2005, 51(12):1341-1350  

Gastroesophageal reflux disease (GERD) is one of the most common diseases affecting upper gastrointestinal tract. It is a chronic disease, whith stadily growing incidence and prevalence in west countries during last 30 years. GERD is caused by pathologic gastroesophageal reflux (GER). GERD includes endoscopically positive, endoscopically negative and extraesophageal reflux disease. Extraesophageal symptoms of GERD have been of a growing attention and discussion during last few years. The most discussed topics are the relation of GERD and bronchial asthma (BA), chronic cough and symptomatology from ear, nose and throught (ENT) regions, but also non...

Evaluation of labeling and content of probiotics available in the Czech Republic

V. Příbramská, J. Juránková, J. Lata, M. Šenkyřík, R. Kroupa

Vnitr Lek 2005, 51(12):1351-1355  

Probiotics are live cultures of mikroorganisms which are good for human health and are used in human medicine as a treatment. Advantageous effect on a human health was proved in many studies in Europe and in the USA. On the other hand, many studies described lack of information about products containing probiotics - in particular the real bacterial strain or quantity of bacteria. We tried to evaluate thirteen products containing probiotics available in the Czech Republic. In all cases the leaflets contained information about the species and amount of bacteria (from seven products containing more than one species of bacteria were only in two cases declared...

The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency

V. Olšovská, H. Šiprová, M. Beránek, V. Soška

Vnitr Lek 2005, 51(12):1356-1364  

Influence of recombinant human procalcitonin on phagocytic and candidacidal ability of polymorphonuclear leukocytes and on killing mechanisms of serum and blood against bacteria Staphylococcus aureus and Escherichia coli

T. Pinčíková, M. Bucová, L. Slobodníková

Vnitr Lek 2005, 51(12):1365-1370  

Procalcitonin (PCT) is a highly selective and specific marker for early diagnosis of sepsis. There is enough information confirming that procalcitonin should be considered as an important mediator in the pathophysiology of sepsis. The aim of our work was to evaluate the effect of recombinant human procalcitonin (rhPCT) on phagocytic and candidacidal activity of polymorphonuclear leukocytes (PMNL) in blood, as well as on killing mechanisms of fresh serum and blood against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). Our results show that rhPCT dose dependently decreased both phagocytic and candidacidal...

Guidelines

Diagnostics and treatment of hepatocellular carcinoma

R. Brůha, P. Drastich, P. Hůlek, J. Lata, J. Petrtýl, J. Procházka, J. Špičák, T. Vaňásek, M. Volfová, P. Zdeněk

Vnitr Lek 2005, 51(12):1406-1408  

Reviews

Possibilities of ultrasonographic differentiation of neck and axillary lymphadenopathy

I. Hrazdira, M. Krupová, H. Kyselová

Vnitr Lek 2005, 51(12):1371-1374  

Technical development of ultrasonography connected with improvement of resolving power has enlarged possibilities in detection and differentiation of lymph nodes. In the current clinical practice ultrasonic examination is most frequently requested for assessment of lymph nodes in neck and axillary regions in connection with inflammatory or tumour diseases. Although the final diagnosis must be confirmed histopathologically, there exist some echographic criteria enabling with a great probability to appoint the malignant character of lymph nodes: round shape expressed by the shape index near to 1, sharp edges, heterogeneous echostructure and mainly loss...

Idiopathic pulmonary fibrosis

M. Doubková, J. Skřičková

Vnitr Lek 2005, 51(12):1375-1384  

Idiopathic pulmonary fibrosis (IPF), known in Europe as cryptogenic fibrosing alveolitis, is a rare, progressive and usually fatal form of idiopathic interstitial pneumonia. IPF is characterized by failure of alveolar re-epithelization, persistence of fibroblasts, deposition of extracellular matrix, and distortion of lung architecture which ultimately results in respiratory failure. Current consensus statements reserve the term IPF to refer to a specific clinical entity associated with the histopatological pattern of usual interstitial pneumonia (UIP). UIP is characterized by temporal heterogeneity, with alternating areas of interstitial fibrosis,...

The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia

L. Chrobák, J. Voglová

Vnitr Lek 2005, 51(12):1385-1393  

Idiopathic hypereosinophilic syndrome is a heterogenous group of hematological disorders characterized by eosinophilia (> 1.5 x 109/l) persistent for more than 6 months, exclusion of reactive eosinophilia from other causes, such as parasitic infections or allergy, and evidence of end-organ damage [22]. According to World Health Organization the exclusion includes all neoplastic disorders in which eosinophils are part of the neoplastic clone. Excluded should be also T cell population with aberant phenotype and abnormal cytokine production [7], recently considert also as "lymphocytic" variants of the HES [42]. HES has to be reclassified...

Prevention of cardiovascular events by the antihypertensive treatment using amlodipine and perindopril in comparison with the use of atenolol and bendroflumethiazide. The ASCOT (Anglo-Scandinavian Outcomes Trial: blood pressure lowe ring arm) study results - multicentre, randomised, controlled trial. Landmark in the development of opinions on combination therapy in hypertension? (comment)

J. Widimský jr.

Vnitr Lek 2005, 51(12):1394-1399  

Case reports

Atypical localisation of pyoderma gangraenosum in patient with ulcerative colitis

L. Husová, P. Husa, R. Berger, J. Feit, V. Hauerová, R. Pařízková, R. Kroupa

Vnitr Lek 2005, 51(12):1400-1405  

From scholarly literature

Z odborné literatury

Vnitr Lek 2005, 51(12):1417-1419  

Varia

Food intolerance - a cause or a consequence of digestive disorders?

Z. Mařatka

Vnitr Lek 2005, 51(12):1409-1411  

Dopis redakci. Přínos pioglitazonu u pacientů s diabetes mellitus 2. typu a kardiovaskulárními komplikacemi

J. Olšovský

Vnitr Lek 2005, 51(12):1412  

From the History of Medicine

200 let od narození Josefa Škody (10. 12. 1805 - 13. 6. 1881)

Ladislav Chrobák

Vnitr Lek 2005, 51(12):1414-1415  

Personalia

75 let prof. MUDr. Karla Trnavského, DrSc.

Miroslav Vykydal

Vnitr Lek 2005, 51(12):1413  

Symposium News

XII. výroční kongres České internistické společnosti ČLS J. E. Purkyně Praha 23. - 25. 10. 2005

Miroslav Souček, Petr Svačina

Vnitr Lek 2005, 51(12):1416  


Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.